News

Filter

Current filters:

GenentechBayer

1 to 9 of 67 results

Avastin remains preferred DME therapy, despite Lucentis extended label in USA

30-05-2013

Despite the approval of Swiss drug major Roche (ROG: SIX) subsidiary Genentech's Lucentis (ranibizumab…

AvastinBayerBiotechnologyEyleaGenentechLucentisMarkets & MarketingNorth AmericaOphthalmicsPharmaceuticalRegeneronRoche

CLARIFICATION: Genzyme's Campath Ph II trial results

27-10-2008

Clarification: In a story from the October 16 update to our web site, we reported data from a Phase II...

AlemtuzumabAspirinBayerBayerCampathGenentechGenzymeRituxanrituximab

1 to 9 of 67 results

COMPANY SPOTLIGHT

Menarini

Back to top